Trueblood Wealth Management’s First Trust Dorsey Wright International Focus 5 ETF IFV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.66M Buy
98,678
+2,896
+3% +$79.3K 0.93% 17
2026
Q1
$2.42M Buy
95,782
+4,390
+5% +$115K 0.95% 18
2025
Q4
$2.27M Buy
91,392
+4,767
+6% +$116K 0.89% 18
2025
Q3
$2.12M Buy
86,625
+4,353
+5% +$103K 0.83% 20
2025
Q2
$1.89M Buy
82,272
+6,162
+8% +$131K 0.79% 27
2025
Q1
$1.52M Buy
76,110
+20,015
+36% +$394K 0.71% 34
2024
Q4
$1.08M Buy
56,095
+8,992
+19% +$179K 0.53% 57
2024
Q3
$991K Buy
47,103
+316
+0.7% +$6.38K 0.5% 64
2024
Q2
$920K Buy
46,787
+2,749
+6% +$54.3K 0.52% 60
2024
Q1
$881K Sell
44,038
-82
-0.2% -$1.6K 0.5% 63
2023
Q4
$862K Buy
+44,120
New +$800K 0.54% 57

Other funds holding IFV

Trueblood Wealth Management's IFV Position: Q2 2026 in Review

Trueblood Wealth Management increased its First Trust Dorsey Wright International Focus 5 ETF (IFV) stake by 3% in Q2 2026, buying an estimated $79.3K and bringing the position to 98,678 shares worth $2.66M. The position accounts for 0.93% of the portfolio, ranked #17.

Trueblood Wealth Management first reported a position in IFV in Q4 2023 and has held it in 11 quarters since. 58 funds tracked by Wall St. Rank hold IFV as of Q2 2026.

  • Trueblood Wealth Management held 98,678 shares of First Trust Dorsey Wright International Focus 5 ETF worth $2.66M as of Q2 2026.
  • Trueblood Wealth Management bought 2,896 First Trust Dorsey Wright International Focus 5 ETF shares in Q2 2026, an estimated $79.3K.
  • First Trust Dorsey Wright International Focus 5 ETF made up 0.93% of Trueblood Wealth Management's portfolio in Q2 2026, its #17 holding.
  • Trueblood Wealth Management first reported a position in First Trust Dorsey Wright International Focus 5 ETF in Q4 2023 and has held it in 11 quarters since.
  • 58 funds tracked by Wall St. Rank held First Trust Dorsey Wright International Focus 5 ETF as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.